Emergency Medicine Palliative Care Access
Public ClinicalTrials.gov record NCT03325985. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Emergency Medicine Palliative Care Access (EMPallA)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a two-arm, multi-site randomized controlled trial of 1,350 older adults (50+ years) with either advanced cancer (defined as metastatic solid tumor) or poor prognosis end-stage organ failure (New York Heart Association (NYHA) Class III or IV Congestive Heart Failure (CHF), End-Stage Renal Disease (ESRD), defined as Glomerular Filtration Rate (GFR) \< 15 ml/min/m2 or dialysis ; or Global Initiative for Chronic Obstructive Lung Disease (GOLD) Stage III or higher, or oxygen-dependent chronic obstructive pulmonary disease (COPD) who present to the Emergency Department (ED), along with 675 of their informal caregivers. Investigators will compare the effectiveness of two distinct palliative care models: a) nurse-led telephonic case management; and b) facilitated, outpatient specialty palliative care.
Study identification
- NCT ID
- NCT03325985
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 1,606 participants
Conditions and interventions
Conditions
Interventions
- Nurse-led telephonic case management Behavioral
- Facilitated,outpatient specialty palliative care Behavioral
Behavioral
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 27, 2018
- Primary completion
- Aug 23, 2023
- Completion
- Aug 23, 2023
- Last update posted
- Jan 12, 2025
2018 – 2023
United States locations
- U.S. sites
- 18
- U.S. states
- 9
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California, Los Angeles Ronald Reagan Medical Center | Los Angeles | California | 90095 | — |
| University of California Irvine Medical Center | Orange | California | 92868 | — |
| University of California San Diego Medical Center | San Diego | California | 92103 | — |
| Yale University | New Haven | Connecticut | 06510 | — |
| University of Florida (UF) | Gainesville | Florida | 32611 | — |
| Northwestern Memorial Hospital | Chicago | Illinois | 60611 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| Brigham and Women's Hospital/Dana-Farber Cancer Institute | Boston | Massachusetts | 02115 | — |
| Henry Ford Health System | Detroit | Michigan | 48202 | — |
| Beaumont Health | Royal Oak | Michigan | 48073 | — |
| William Beaumont Hospital, Troy | Troy | Michigan | 48085 | — |
| Hackensack University Medical Center | Hackensack | New Jersey | 07601 | — |
| Atlantic Health System, Morristown Medical Center | Morristown | New Jersey | 07960 | — |
| NYU Langone Hospital- Brooklyn | Brooklyn | New York | 11220 | — |
| NYU Langone Health Hospital Long Island | Mineola | New York | 11501 | — |
| Bellevue Hospital | New York | New York | 10016 | — |
| New York University Langone Tisch Hospital | New York | New York | 10016 | — |
| Ohio State University (OSU) | Columbus | Ohio | 43210 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03325985, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 12, 2025 · Synced Sep 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03325985 live on ClinicalTrials.gov.